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Limited proteolysis has been utilized to study the 
structu ra l organization of rabbit skeletal muscle 
myosin light chain kinase. The enzyme (Mr — 89,000 
by sodium dodecyl sulfate-polyacrylam ide gel electro­
phoresis) consists of an  am ino-term inal, protease-sus­
ceptible region of unidentified function and a  carboxyl- 
term inal, protease-resistant region of M r — 40,000 
containing the cataly tic and calmodulin-binding do­
mains. P artia l digestion w ith trypsin produced an in­
term ediate 56 ,000-dal ton fragm ent and a stable 
38,000-dalton fragm ent, both of which w ere eatalyti- 
cally active and calmodulin-dependent. Chymotryptic 
digestion yielded three catalytically active fragm ents 
of about 37,000, 36,000, and 35,000 daltons. The M r 
=  37,000 fragm ent was calm odulin-dependent w ith an 
apparent affinity  equivalent to th a t of the native en­
zyme (~1 nM). The 36,000-dalton fragm ent was also 
calm odulin-dependent but had a —200-fold lower ap­
parent affinity. The M r = 35,000 fragm ent was cal­
m odulin-independent. These three chym otryptic frag ' 
ments, had identical amino term ini. Nineteen residues 
w ere missing from the carboxyl term inus of the cal­
m odulin-independent chym otryptic fragm ent w hereas 
only 8 or 9 carboxyl-term inal residues were missing 
from the calm odulin-dependent tryp tic  fragm ents. 
These results suggest tha t the 11-residue sequence 
(IAVSAANRFKK) in the carboxyl-term inal region of 
myosin light chain kinase contributes directly to the 
binding of calmodulin. This conclusion is in accord 
w ith data (Blumenthal, D. K., Takio, K., Edelman, A. 
M., Charbonneau, H., T itani, K., Walsh, K. A., and 
Krebs, E. G. (1985) Proc. Natl. Acad. Sci. U. S. A. 82, 
3187—3191) tha t the carboxyl-term inal, 27-residue 
CNBr peptide of the  native en2yme shows Ca2+-de­
pendent, high affinity  binding to calmodulin and that 
sim ilar calm odulin-binding activity , although detect­
able in unfractionated CNBr digests of calmodulin- 
dependent enzyme forms, is much reduced in a  CNBr 
digest of the calm odulin-independent, M r = 35,000 
chym otryptic fragm ent.
This phosphorylation is thought to play an obligatory role in 
the contractile process in smooth muscle and a modulatory 
role in contraction in skeletal muscle (for reviews, see Refs. 1 
and 2). The enzyme exists in a wide spectrum of tissue- and 
species-specific isozymic forms (1-4). In skeletal muscle, the 
enzyme has a molecular weight of between 75,000 and 150,000 
depending on the species (3, 4), As purified from rahbit 
skeletal muscle, it is monomeric, with a molecular weight 
estimated to be —80,000-91,000 by SDS-PAGE1 (5-10). How­
ever, since values of 70,000-75,000 daltons have been reported 
by sedimentation equilibrium measurements (8, 10), the val­
ues by SDS-PAGE may be anomalously high.
A number of reports have described proteolytic fragments 
of skeletal muscle myosin light chain kinase retaining cata­
lytic activity (5,10,11, 13). In an early observation, Pires and 
Perry (5) reported that enzymatically active fragments with 
molecular weights of 50,000 and 30,000 were generated upon 
storage of the native enzyme at 2 °C. Tanaka e t al. (11) 
reported that trypsin treatment converted the enzyme to a 
state that no longer required CaI+ and calmodulin for activity, 
although they did not provide physical characterization of the 
fragment(s) responsible for this activity. In contrast, Wais- 
man et al. (12) failed to observe such an effect in similar 
studies using trypsin, and Mayr and Heilmeyer (10) used 
trypsin and an endogenous protease in their kinase prepara­
tion to generate calmodulin-regulated fragments of M T ~  
36,000. Srivastava and Hart.shorne (13) reported that limited 
chymotryptic treatment generated a 65,000-dalton fragment 
whose activity was independent of Ca'i+ and calmodulin.
Detailed knowledge of the kinetic aspects of the interaction 
of calmodulin and skeletal muscle myosin light chain kinase 
is currently available (7, 8, 14). There is, nevertheless, little 
structural information concerning this interaction and an 
incomplete or conflicting picture (see data cited above) of the 
domain structure of the enzyme as analyzed by limited pro­
teolysis. We therefore undertook an investigation of the na­
ture and relative positioning of its catalytic and calmodulin- 
binding domains. This report represents one of three articles 
from our laboratories on this topic. In Blumenthal et at. (15) 
we demonstrated that the carboxyl-terminal, 27-residue cyan-
Myosin light chain kinase phosphorylates, in a Ca2+- and 
calmodulin-dependent manner, one of the light chain subunits 
of myosin (light chain 2: M , =  18,500 in skeletal muscle).
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ogen bromide fragment of myosin light chain kinase has the 
ability to bind calmodulin in a Ca5+-dependent manner and 
with high affinity. In Takio et a l  (16) we present the amino 
acid sequence of the carboxyl-terminal ~60% of the enzyme, 
a region containing both the catalytic and calmodulin-binding 
domains. In this article we describe the generation, purifica­
tion, and enzymatic characterization of a series of catalytically 
active proteolytic fragments derived from the carboxyl-ter­
minal part of the enzyme. Four of the fragments were found 
to be calmodulin-regulated whereas one (the smallest chy- 
motryptic fragment) was unresponsive to calmodulin. Amino- 
and carboxyl-terminal sequence analysis on this latter frag­
ment and on calmodulin-dependent fragments suggested that 
the carboxyl-terminal 20 residues contain determinants crit­
ical for calmodulin-interaction. Thus, the data presented in 
these three reports support a model in which the carboxyl- 
terminal half of myosin light chain kinase contains both the 
catalytic and calmodulin-binding domains with the latter 
occupying the -3 0  amino acid residues at the extreme car­
boxyl terminus. Taken together, these data provide the first 
details of the primary structure of a calmodulin-binding do­
main in a calmodulin-regulated enzyme and may, therefore, 
aid in the elucidation of the structuTes of calmodulin-binding 
sites in other calmodulin-regulated enzymes.
EXPERIMENTAL PROCEDURES 
Materials!
:t-( hv'i'.Mrvp-wii, T PC K -treated  trypsin, and  lima bean trypsin 
inhibitor {LBTI) were obtained from W orthington. Staphylococcus 
aureus (V#) protease, bovine serum album in, and hum an IgG were 
from Miles Laboratories. Leupeptin was purchased from Peninsula 
Laboratories. Phenylmethylsulfonyl fluoride and pancreatic trypsin 
inhibitor were obtained from Sigma. [7 **P]ATP was supplied by 
New England Nuclear. Ail other chemicals used were reagent grade 
or better. Myosin light chain kinase was prepared from rabbit skeletal 
muscle by a large-scale m ethod described in detail elsewhere (16). 
Mixed myosin light chains from rabbit skeletal muscle were prepared 
by a published m ethod (7). The procedure for removing endogenous 
calmodulin from the light chains was as described (9) with m inor 
modifications. Bovine brain or erythrocyte calmodulin was purified 
by DEAE- and fluphenazine-Sepharose essentially as described by 
Kakiuchi et al. (171. Calmodulin affinity columns were prepared using 
either CNBr-activated Sepharose 4B (Pharm acia) or Affi-Gel 15 (Bio­
Rad) according to m anufacturers' instructions with minor modifica­
tions.
Myosin Light Chain Kinase .4wav
Myosin light chain kinase was assayed basically as described (9). 
P rior to assay, enzyme dilutions were made in a buffer containing 10 
mM MOPS, pH 7, 1 mg/ml bovine serum album in, 1 mM EDTA, 0.1 
m NaCl, and 0.5-1.0 mM D T T  (buffer A). Assays were performed 
either with mixed myosin light chains or with calmodulin-free mixed 
myosin light chains for the  determ ination of activation constants. 
The concentration of the phosphorylatable light chain in these assays 
(—50 uM) was determined by maximal 13P incorporation. Assays 
performed in the presence of Ca2+ and calmodulin contained sa tu rat­
ing concentrations of both (€.4 mM Ca2* in excess of chelator and 
— 1 nM calmodulin). Assays performed in the  absence of CaJ* and 
calmodulin contained no added calmodulin and EGTA §  2 mM in 
excess of Ca!+.
Preparation of Calmodulin-dependent Tryptic Fragments (Te, 1\ITp)
Tg—myosin light chain kinase (3.6 mg) in 60 m M  M OPS, pH 7.2,
2 m M  EGTA, 1 m M  DTT, 0.2 M NaCl was incubated a t 22 *C with
3.1 fig of T PC K -treated trypsin in a final volume of 2.64 ml. At 
various times, separate sets o f aliquots were removed for SDS-PAGE 
and myosin light chain kinase activity determ inations. LBTI was 
added to each aliquot to term inate proteolysis (LB TI/trypsin: 34/1, 
w/w). T he aliquots for activity m easurem ents were also diluted 10­
fold in buffer A. All aliquots were frozen on dry ice immediately after 
additions and then stored a t —70 *C prior to  analysis. T he control
reaction was performed and processed identically bu t without pro­
tease. After 20 min, an aliquot (3.36 mg of myosin light chain kinase) 
was removed and LBTI added to term inate proteolysis (L B T I/tryp­
sin: 34/1, w/w). The m ixture was then  applied to a Sephacryl S-200 
(Pharm acia) column (1 x  115 cm) equilibrated in 10 mM MOPS, pH
7, 0.5 mM EDTA, 2.5 mM D TT, and 0.1 M NaCl and chromatographed 
(4 ’C) a t a flow rate of 5,8 m l/h. From the  1.4-m] column fractions, 
separate aliquots were removed for SDS-PAGE and myosin light 
chain kinase activity measurements after dilution in buffer A, T a is 
defined as the  pool of S-200 fractions 41-46.
T , / T j —A m ixture of tryptic fragments (afp: 1,8/1.0 by sequence 
analysis) was prepared by treating 3 mg of myosin light chain kinase 
in 5 rtiM MOPS, pH 6.5, 5 mM DTT, and 0.1 M NaCl with TPCK- 
treated trypsin (3 <^ g) a t 22 *C for 30 min in a  final volume of 4.29 
ml. The digestion was term inated by a 70-fold weight excess of LBTI 
or in the  case of utilization for sequence analysis by the addition of 
trichloroacetic acid to a final concentration of 10% (w/v).
Preparation of Calmodulin-dependent Chymotryptic Fragments 
(C?)7, Cs36)
Myosin light chain kinase (1.94 mg) in 5 m M  MOPS, pH  7,0.5 m M  
EDTA, 1 m M  DTT, and 0.3 M NaCl was incubated a t 22 ’C with 8.4 
lig o f chymotrypsin in a final volume of 4.28 ml. At various times 
aliquots were removed, added to phenylmethylsulfonyl fluoride (0.5 
mM, final concentration) to stop proteolysis, frozen on dry ice, and 
stored a t —70 *C for subsequent analysis by myosin light chain kinase 
assay and SDS-PAGE, T he control reaction was performed and 
processed identically bu t without addition of protease. After 10 min, 
to an  aliquot containing 1.87 mg of myosin light chain kinase, 
phenylmethylsulfonyl fluoride was added to a final concentration of 
0.5 m M . T he mixture was then  applied to a Sephacryl S-200 gel 
filtration column (1.6 x  92 cm) equilibrated in 5 m M  MOPS, pH  7, 
0.5 m M  EDTA, 2 mM DTT, and 0.1 M NaCl and chromatographed 
(4 ’C) a t  a flow rate of 14 m l/h. From the 1.3-ml column fractions, 
aliquots were removed for SDS-PAGE and  myosin light chain kinase 
assay. Fractions 76-83 were pooled (10.4 ml). After removal of an
0.7-ml aliquot, the rem ainder was adjusted with CaCl2 to  a final 
concentration of 1 m M  and applied to a calmodulin Sepharose column 
(4 "C; 0.7 x  8.5 cm; coupling density: ~0.25 mg of calm odulin/ml of 
resin) equilibrated in 10 m M  MOPS, pH  7,100 /iM CaCl2, 1 m M  DTT, 
and 0.1 M NaCl. T he column was then  washed with an additional 2.1 
ml of th is buffer and the flow-through collected in three fractions. 
Flow-through fractions 1 and 2 were combined and are term ed C^36. 
The third flow-through fraction contained a minimal am ount of 
protein and was discarded. Elution was with the equilibration buffer 
containing 1 mM EDTA. Those fractions in the eluate containing 
protein were pooled and designated (\3 7
Preparation of the Calmodulin-independent Fragment (Cg35J
Myosin light chain kinase (8.63 mg) in 90 mM MOPS, pH  7.2, 0.5 
mM EDTA, 1 mM DTT, 0.1 M NaCl was incubated a t 22 *C with 43 
^g of chymotrypsin in a final volume of 2.09 ml. At various times, 
separate sets of aliquots were removed for SDS-PAGE and myosin 
light chain kinase activity determinations. LBTI was added to  each 
a liq u o tto te rm inatep ro teo lysis(L B T I/c  hy motrypsin: 34/1, w/w). T o 
the aliquots for activity measurements, 0.9 mg/ml bovine serum 
album in was also added. All aliquots were frozen on dry ice immedi­
ately after additions and then stored a t -7 0  *C prior to analysis. The 
control reaction was performed and processed identically but without 
protease. After 20 min, an aliquot containing 6.86 mg of myosin light 
chain kinase was removed, and chymotrypsin inactivated with a 20­
fold weight excess of LBTI, The mixture was then subjected to HPLC 
gel filtration (22 ’C) a t a flow rate of 2.5 m)/min on a Bio-Si) TSK- 
250 preparative column (G3000SW; 21.5 X 600 mm), equilibrated in 
10 m M  M OPS, pH  6.8, 0.5 m M  EDTA, 1 mM D TT, and 0.1 M NaCl. 
Fractions containing activity were pooled and adjusted with CaCl3 to 
a final concentration of 1 mM. The pool was applied to a column 
(4 °C; 0.7 x  4.2 cm) of calmodulin immobilized on Affi-Gel-15 (cou­
pling density: —1 mg of calm odulin/ml resin) equilibrated in 10 mM 
MOPS, pH  7, 100 CaClj, 1 mM DTT, and 0.1 M NaCl. The column 
was then  washed with an additional 2.5-column volumes of the 
equilibration buffer and elution was with th is buffer containing 2 mM 
EGTA substituted for CaCla. Protein containing flow-through frac­
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FlO. 1. L im ited d igestion of myosin ligh t chain  k inase  w ith  try p sin , chym otrypsin , o r 5. aureus  (V8) 
p ro tease . Myosin light chain kinase (96 /ig/150-^1 reaction) was incubated on ice in separate reactions with 
trypsin (‘2.0 ng), chymotrypsin (2.3 pg), or S. aureus (V8) protease (5.8 fig). The reactions also contained 0.08 M 
Tris. pH 7.5, 0.01 M MOPS, pH 7, 0.08 M NaCl, 0.8 mM DTT, 0.8 mM EDTA, 8% (v/v) glycerol. At the indicated 
times, aliquots (4.4 fig from the trypsin and chymotrypsin incubations, and 5.5 tig from the S. aureus (Vs) protease 
incubation) were added to protease inhibitor mixtures containing (in final concentrations): pancreatic trypsin 
inhibitor (15 fig/m\), leupeptin (0.11 mM) phenylmethylsulfonyl fluoride (2.8%, w/v), and ethanol (2.6%, v/v). 
Samples were then prepared for and subjected to SDS-PAGE as described under “Experimental Procedures.” A 
and B represent separate gels. For the zero time points trypsin, chymotrypsin, or H20  (no protease condition) were 
preincubated with the protease inhibitor mixture before addition to the kinase.
T able I






mg nmol/ min nmol/min/mg %
A. Tryptic fragment
Intact myosin light chain kinase 3.30 27.2 8.24 99.5
S-200 pool (Fractions 41-46:T„) 0.857 6.85 7.99 99.6
B. Chymotryptic fragments
Intact myosin light chain kinase 1.64 12.24 7.47 99.6
S-200 Pool 0.476 4.84 10.20 98.5
Calmodulin affinity column flow through (Cn36) 0.332 3.09 9.31 100.0
Calmodulin affinity column chelator eluate (Cd37) 0.029 0.332 11.45 98.4
"Calmodulin dependence (%) is defined as:
1 - Activity in the absence of calmodulin and presence of EGTA
Activity in the presence of saturating concentrations of Ca2’ and calmodulin=)«100.
Selective Cleavage and Sequence Analysis
Intact myosin light chain kinase and fragments of limited prote­
olysis were reduced, and carboxymethylated as described by Takio et 
al. (18), then acidified and separated from the reagents and contam­
inating smaller fragments on TSK gel filtration columns as described 
(see Fig. 11, legend). Pooled fractions were desalted on a Sephadex 
G-25 column in 9% (v/v) formic acid and lyophilized. Methionyl 
bonds were cleaved with 1% (w/v) CNBr in 70% (v/v) formic acid 
(—10 mg/ml protein) for 6 h at room temperature. Primary separation 
of CNBr fragments was achieved by TSK gel filtration as described 
in the legend to Fig. 11. Amino acid analysis was performed with a 
Dionex D500 Amino Acid Analyzer or a Waters Pico-Tag system (19, 
20). Automated Edman degradations were carried out on a gas-phase 
protein sequencer (model 470A, Applied Biosystems) with a program 
adapted from Hunkapiller et al. (21). Phenylthiohydantoins were 
identified in a semiquantitative manner by two complementary 
HPLC systems (22, 23).
Gel Electrophoresis
Samples were prepared by heating at >90 °C for 3-5 min in 1% 
(w/v) SDS, 2% (v/v) ff-mercaptoethanol, and 8% (v/v) glycerol. SDS- 
PAGE was performed as described (24) using either 20% acrylamide, 
0.08% bisacrvlamide or 15% acrylamide, 0.15% bisacrylamide in the 
running gels. The following M, standards (Bio-Rad) were used: phos­
phorylase b (97,400), bovine serum albumin (66,200), ovalbumin 
(44,000), carbonic anhydrase (29,000), soybean trypsin inhibitor 
(21,500), and lysozyme (14,400).
Other Methods
Protein concentrations were determined as described by Bradford 
(25), using bovine serum albumin as standard, or by the method of 
Lowry et aL (26), with some of the modifications suggested by Peter­
son (27), using human IgG as standard. Calmodulin concentrations 
were measured by UV absorbance using E'jh =  2.0 (28).
RESULTS
Isolation and Characterization of Enzymatically Active Frag­
m ents of Myosin Light Chain Kinase Generated by Limited  
Proteolysis—Initial experiments showed that when purified 
rabbit skeletal muscle myosin light chain kinase was subjected 
to limited proteolysis the fragmentation pattern obtained was 
largely independent of the type of protease used (Fig. 1, A 
and B). S. aureus (V8) protease, trypsin, or chymotrypsin, all 
produced a similar pattern as analyzed by SDS-PAGE. The 
enzyme (M , =  89,000) was rapidly degraded to an M, = 35,000­
40,000 fragment which was largely resistant to further prote­
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Time (minutes)
Fig. 2. L im ited try p tic  d igestion  o f myosin ligh t chain  k inase (MLCK). Myosin light chain kinase was 
subjected to limited digestion with TPCK-treated trypsin as described under “Experimental Procedures” (T« 
preparation), l^eft panel, kinase assay of selected time points from the following reactions: trypsin treated, assayed
with Ca2*, calmodulin (▲----- A); no protease, assayed with Ca2*, calmodulin ( • ----- • ) ;  trypsin treated, assayed
without Ca2*, calmodulin (EGTA included) (▲----- A); no protease, assayed without Ca2*, calmodulin (EGTA
included) ( • ----- • ) .  Right panel, SDS-PAGE of selected time points. Times are shown above the gel in minutes.
Zero time points in this case represent —20 s of incubation with, or without (control), trypsin. Each lane contained 
8.4 >ig. Molecular mass values are in kilodaltons. Arrows indicate positions of T„ and Tj.
Table II
Activation constants (Km )  for calmodulin of isolated forms of skeletal 











FlG. 3. S ephacry l S -200  gel filtra tio n  ch rom atography  of a 
lim ited try p tic  d igest o f myosin light chain  k inase. After 20 
min of limited tryptic digestion (Fig. 2), T„ and T„ were separated by 
Sephacryl S-200 gel filtration chromatography as described under 
"Experimental Procedures” (T„ preparation). Myosin light chain 
kinase activity (shown in the upper panel) was determined in the 
presence (• !  or absence (O) of Ca2* and calmodulin (EGTA included) 
as described under “Experimental Procedures." SDS-PAGE of 60-*il 
aliquots of fractions 37-45 (alternate fractions) are shown in the 
lower panel. Fractions 29-35 and 47-71 were also electrophoresed but 
showed no protein staining and are therefore not shown. Arrows 
indicate the positions of T„ and Ta.
quence analysis established that these fragments correspond 
to the carboxyl-terminal -50-60%  of the molecule (16). The 
lack of obvious stained peptides representing the amino ter­
minal part of the molecule suggested that by contrast, the
° Defined as the calmodulin concentration required for half-maxi­
mal activation.
6 NA, non-activated; tested at a calmodulin concentration of 5 jiM.
latter has an extended structure and is therefore quickly 
digested or very poorly stained by Coomassie Blue.
Milder treatment with trypsin revealed a fragment of M , ~  
60,000 as well as the stable M, -  40,000 fragment (Fig. 2). 
The appearance and disappearance of these fragments with 
time, as well as their enzymatic and primary structural char­
acteristics (discussed below and in Takio e t al. (16)), suggested 
that the M , ~  60,000 fragment is further degraded to form 
the M, ~  40,000 fragment. These tryptic fragments are re­
ferred to here and in Takio et al. (16) as T„ and To, respec­
tively. They were previously referred to as T60 and T40, 
respectively (15). The molecular weights of T„ and Td are 
~50,000 and 41,006 by their amino acid sequences (16) or 
55,800 and 38,200 by SDS-PAGE, respectively. Fig. 2 shows 
that after 10 min of digestion, although there was no intact 
kinase left, a considerable amount of activity (70%) remained, 
demonstrating that the fragments were collectively, catalyti- 
cally active. By 20 min only T„ is evident and is catalytically 
active. Some activity is lost during the digestion suggesting 
that the remainder of the molecule may be required for the 
maintenance of maximal activity. At all time points through­
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FlO. 4. SDS-PAGE of a  lim ited 
chym otryptic  d igestion o f myosin 
light chain k inase. Myosin light chain 
kinase was subjected to limited chymo­
tryptic digestion and aliquots (3.1 tig) 
taken at selected time points were ana­
lyzed by SDS-PAGE ("Experimental 
Procedures:" Cs37, C«36 preparation). 
The time points selected are shown 
above the gel in minutes. For the zero 
time points the order of addition of 
phenylmethylsulfonyl fluoride and pro­
tease (or H20  for the control reaction) 
was reversed. Molecular mass values are 
in kilodaltons. Arrows indicate the posi­
tions of C„37, 0*36, and C^fi.
C h y m o t r y p s i n  C o n t r o l
i  r
60 24 10 4 0 60 0
M r 
1-97  
- 6 6  











FlG. 5. Myosin light chain  k inase  (MLCK) ac tiv ity  as a 
function  of tim e d u rin g  lim ited  chym otryptic  digestion.
Myosin light chain kinase was subjected to limited chymotryptic 
digestion as described under “Experimental Procedures” (Cj37, Cp36 
preparation). Myosin light chain kinase activity was determined at 
selected time points from the following reactions: chymotrypsin
treated, assayed with Ca2*, calmodulin (A------A); no protease, assayed
with Ca2*, calmodulin ( • ----- • ) ;  chymotrypsin treated, assayed with­
out Ca2*, calmodulin (EGTA included) ( A -------A); no protease,
assayed without Ca2*, calmodulin (EGTA included) ( • ----- • ) .
pendent. After 20 min an aliquot of the reaction mixture 
(after the addition of an excess of protease inhibitor) was 
subjected to Sephacryl S-200 gel filtration as shown in Fig. 3. 
Both T„ and T,, demonstrated Ca2*-calmodulin-dependent 
enzyme activities (see also Takio et al. (16)). The pool of 
fractions 41-46 yielded an electrophoretically homogenous 
preparation of T,(. Table 1(A) summarizes the purification of
- 2 1
- 1 4
Ta. On a molar basis, its specific activity (304 ^mol/min/ 
fimol) was about 40% that of the intact enzyme (733 jimol/ 
min/Vmol). Isolated Trt or an unfractionated mixture of T„ 
and Tfj (see “Experimental Procedures”) showed modest in­
creases in their activation constants for calmodulin (Table
II).
We also examined in greater detail the cleavage pattern 
obtained with chymotrypsin. At a lower chymotrypsin/kinase 
ratio than that used in the experiment shown in Fig. 1 A , three 
fragments were obtained having molecular weights by SDS- 
PAGE of 36,700, 35,500, and 34,600 (Fig. 4). In Takio et al. 
(16), we describe the generation of chymotryptic fragments 
for sequencing purposes. The chymotryptic fragment there 
termed C# appears to be a mixture of the ~37-, 36-, and 35- 
kilodalton fragments shown here. In this report, therefore, we 
use the terminology 0*37, Ctf36, and C„35. Fragment C#35, 
earlier termed C35 (15), has a molecular weight by amino acid 
sequence of 37,657 (Fig. 12 and Takio et al. (16)). The frag­
mentation pattern with time indicated that Crt37 gives rise to 
0^36 which in turn generates Crf35. Fig. 5 shows that these 
fragments collectively possessed calmodulin-dependent 
myosin light chain kinase activity although there was a some­
what greater drop in overall activity than in the case of the 
limited tryptic digestion (Fig. 2). After 10 min of digestion, at 
which time there were approximately equal amounts of 0^37 
and C^36 (see Fig. 4), an aliquot of the reaction was removed 
and proteolysis stopped with an excess of protease inhibitor. 
The resulting fragments were subjected to Sephacryl S-200 
gel filtration as described under “Experimental Procedures.” 
The kinase activity eluted from the column in two peaks. One 
peak corresponded to undegraded enzyme. The other con­
tained both Co37 and C„36 (not shown). The fractions con­
taining the fragments were pooled and subjected to calmodulin 















11280 Domains in Myosin Light Chain Kinase









Fig. 6. SD S-PAG E of purified chymotryptic fragments 
(Ci37, Cs36) of myosin light chain kinase. Chymotryptic frag­
ments were generated, purified, and analyzed by SDS-PAGE as 
described under “Experimental Procedures” (Cj37, Cj36 preparation). 
Lane 1. 10-min time point of original digestion (3.5 *ig); Lane 2, 60- 
min time point of original digestion (3.5 //g); Lane 3, pool of S-200 
fractions 76-83 (3.4 /ig); Lane 4, EDTA eluate of calmodulin affinity 
column (1.9 ^g); Lanes 5 and 7, flow-through fractions 1 and 2 of the 
calmodulin affinity column (~2.0, ~3.0 ng, respectively); Lane 6, 
calmodulin-independent chymotryptic fragment (Cj35) prepared by 
a procedure similar to that described under “Experimental Proce­
dures” (C,j35 preparation) (1.1 ng). Molecular mass values are in 
kilodaltons. Arrows indicate the positions of C«37, C036, and Cj35.
-Log [Calmodulin]
Fig. 7. A ctivation o f  chym otryp tic  fragm en ts o f myosin 
ligh t chain  k inase  (MLCK) (C»37, Ca36) by calm odulin. Myosin 
light chain kinase activity was determined as a function of calmodulin 
concentration for the chymotryptic fragments C<i37 and C^36, as 
described under “Experimental Procedures." Calmodulin dilutions 
were in buffer A.
Procedures.” The purified fragments obtained by this proce­
dure were analyzed by SDS-PAGE, the results of which are 
shown in Fig. 6. Upon application of the mixture of Ctf37 and 
C»36 obtained by gel filtration (lane 3) to the calmodulin-
Sepharose affinity column in the presence of Ca2+, C,j36 did 
not bind (lanes 5 and 7) whereas 0*37 did and was specifically 
eluted with EDTA (lane 4). Lanes I and 2 show two time 
points in the original digestion included to verify the identity 
of the fragments. As described below, C^35 could also be 
isolated in homogenous form. A sample of C<j35 isolated by a 
similar procedure to that described in detail under “Experi­
mental Procedures” was electrophoresed in lane 6. As can be 
seen, it clearly runs below the bands in lanes 5 and 7 thereby 
confirming the latter as C„36.
Isolated C#37 and C*36 (the latter being the pool of fractions 
shown in lanes 5 and 7 of Fig. 6 ) were examined for their 
abilities to be activated by calmodulin (Fig. 7). Although both 
fragments had an absolute requirement for calmodulin, Cfl36 
had a ~ ‘200-fold lower apparent affinity for calmodulin than 
did C,|37. The K„t of the latter for calmodulin is equal to that 
of the native enzyme (Table II). The low apparent affinity of
C,j36 for calmodulin and the low coupling density of calmo­
dulin in the batch of affinity resin used probably explains 
why Ctf36 did not bind to the affinity column.
The purification of 0^37 and Cri36 is summarized in Table 
1(B). As in the case of Ttf, the fragments were only moderately 
reduced in molar specific activity with respect to the intact 
enzyme and, as was mentioned, were entirely calmodulin- 
dependent.
Preliminary experiments suggested that the smallest of the 
three chymotryptic fragments (Ca35) was also enzymatically 
active but unlike Cg37 and C,(36 was calmodulin-independent 
(data not shown). In order to generate quantities of Cfl35 
sufficient for amino acid sequencing and kinetic characteri­
zation, the digestion procedure used to generate C«37 and 
Cfl36 was modified, as described under “Experimental Proce­
dures,” by the use of a slightly higher chymotrypsin/kinase 
ratio and longer time period. Fig. 8 shows the fragmentation 
and activity patterns during the limited proteolysis. Ca2+- 
calmodulin-independent activity appeared which roughly co­
incided with the appearance of 0^35. After 20 min, an aliquot 
of the reaction was removed, an excess of protease inhibitor 
added, and the mixture subjected to HPLC gel filtration. 
Fractions containing appreciable activity were pooled and 
subjected to calmodulin affinity chromatography. Fig. 9 shows 
that the protein and virtually all of the activity passed directly 
through the calmodulin column in the presence of Ca2+. 
Furthermore, this activity was calmodulin-independent. A 
very small amount of calmodulin-dependent activity was de­
tected in fraction 15 of the EGTA eluate.
As shown in Fig. 10, the final preparation of Ctf35 (consist­
ing of breakthrough fractions from the affinity column) was 
electrophoretically homogeneous (lanes 3 -5 ). Lanes 1 and 2 
are time points in a chymotryptic digestion included to illus­
trate the relative positions of the three fragments. Although 
homogenous by SDS-PAGE, some contamination with larger 
amino-terminal fragments was detected by sequence analysis 
(discussed below).
The purification of C^35 is summarized in Table III. Al­
though considerable loss in activity was sustained, the specific 
activity of the final preparation was still nearly 2 jimol/min/ 
mg. In a replicate generation and purification of C#35, vir­
tually identical results were obtained (specific activity = 1.75 
^mol/min/mg; 0% calmodulin dependence). An unusual as­
pect of this preparation was that although not entirely Ca2*- 
calmodulin independent at the point of stopping the digestion, 
the enzyme was so after the affinity chromatography. A 
possible explanation for this is presented below (see “Discus­
sion”).
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Fig. 8. Limited chymotryptic digestion of myosin light chain kinase (MLCK). Myosin light chain kinase 
was subjected to limited chymotryptic digestion as described under “Experim ental Procedures” (C,i35 preparation). 
Left panel, kinase assay a t selected tim e points from the  following reactions: chymotrypsin-treated, assayed with
Ca2*, calmodulin (A------A); no protease, assayed with Ca2*, calmodulin ( • ------• ) ;  chym otrypsin-treated, assayed
without Ca2*, calmodulin (EGTA included) ( A ------A); no protease, assayed without Ca2*, calmodulin (EGTA
included) ( • ------• ) .  Right panel, SDS-PAGE of selected time points. Tim es are shown above the gel in minutes.
Each lane contained 8.6 /ig. Molecular mass values are in kilodaltons. Arrow indicates the position of Co35.
Wosn Elute
Fraction nynnber
Fig. 9. Calmodulin affinity chromatography of a chymo­
tryptic fragment (Cfl35) of myosin light chain kinase (MLCK). 
Myosin light chain kinase was subjected to limited chymotryptic 
digestion and the active fragment purified by sequential HPLC gel 
filtration and calmodulin affinity chromatography (shown above) as 
described under “Experim ental Procedures" (Ca35 preparation). 
Buffer, 10 mM Mops, pH 7, 1 mM DTT, and 0.1 M NaCl. CaCl2 
concentration during sample application and wash was 100 #iM.
Protein concentrations ( • ------• )  were determined according to the
method of Bradford (25). Myosin light chain kinase was assayed as 
described under “Experim ental Procedures," with Ca2*, calmodulin 
(A------A) or without Ca2*, calmodulin (EGTA included) (□  - • • □).
a very small change (~2200 daltons by SDS-PAGE) in molec­
ular mass converted a Ca2+-calmodulin-dependent enzyme 
(C„37) to an independent one (C„35) and an even smaller 
change (0^36 ~  1200 daltons smaller than C^37) affected the 
apparent affinity for calmodulin, it was obvious that the 
amino and/or the carboxyl termini of these fragments was 
critical for interaction with calmodulin (Table II).
Sequence analysis established the amino termini of 
the isolated enzyme forms generated by limited proteoly­
sis as: T„:RGSPA . . .; T„:GIEF . . . ;  Ctf37:CLPA . . . .;
C((36:CLPA . . . . ;  C ^ C L P A .. . .  The fact that the three 
chymotryptic fragments shared the same amino terminus 
despite the dramatic differences in the ability to interact with 
calmodulin (see Table II) is evidence of the importance of the 
carboxyl-terminal region for this interaction.
Carboxyl-terminal sequence analysis relied on comparisons 
of fingerprints of the cyanogen bromide fragments from whole 
protein (Fig. 11, panel a) and from the products of limited 
tryptic digestion (panel b) or 0*35 (panel c). As seen in panels 
b and c of Fig. 11, the amino-terminal cyanogen bromide 
fragment M l is not present in the digests of T„/T# or of Cri35. 
New amino-terminal fragments are denoted M l' from T„, 
Ml" from Ttf, and M lc from C<j35. A contaminant in Co35 
coeluted with M2. The carboxyl-terminal peptide of the whole 
protein, M13 in panel d, is replaced by M13' in the digest of 
T„/T^ (panel e ), and by M13c in the digest of C«35 (panel h). 
In the case of the digest of C(j35, a new carboxyl-terminal 
fragment was suggested by the increase in the relative peak 
height of M7 (compare panels a and c), and by the disappear­
ance of M13 peaks upon rechromatography on reversed-phase 
HPLC (panel f). This was confirmed by the characterization 
of a new peptide M13' that coeluted with M7 in panel c but 
separated from it in panel h. Sequence analysis of the isolated 
peptides yielded the sequences KRRWKKNFIAV- 
SAANRFKk <M13') and KRRWKKNF (M13c), which may 
be compared with the carboxyl-terminal peptide M13 from 
the whole protein, KRRWKKNFIAVSAANRFKKISSS- 
GALM (16). Sequence analysis of T„ in the absence of T„ 
yielded the same carboxyl terminus seen in the mixture (16). 
Thus, the evidence presented here indicates that the carboxyl 
terminus of the calmodulin-dependent fragment Tg (or T„) is 
only 8 or 9 residues shorter than that of the intact enzyme, 
whereas the carboxyl terminus of the calmodulin-independent 
fragment, C#35, is 19 residues shorter than that of the intact 
enzyme, results consistent with a calmodulin binding domain 
localized to this region.
Fig. 12 is a schematic representation of myosin light chain 
kinase showing the sites of proteolytic cleavage and the pu­
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FlO. 10. SD S-PAG E of a purified chymotryptic fragment 
(C935) of myosin light chain kinase. Cj35 was generated, purified, 
and analyzed by SDS-PAGE as described under “Experimental Pro­
cedures." tjine  /, 4-min time point of chymotryptic digestion shown 
in Fig. 4 (3.1 fig); Lane 2, mixture of 24- and 60-min time points of 
chymotryptic digestion shown in Fig. 4 (4.0 ng); Lane 3, Cj35 (1.1 
/jg); iMne 4, Cn35 (2.2 #ig); Lane 5, Ca35 (6.2 Mg). Molecular mass 
values are in kilodaltons. Arrows indicate positions of C^37, C«36, and
T able III
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6.58 70.2 0.091 10.7 0.01 99.9
TSK G3000 SW 1.38 3.75 1.97 2.72 1.43 47.5
Calmodulin affin­
ity column flow 
through
1.47 2.83 2.69 1.93 1.83 4.9
* Defined as in Table I.
approximate location of the catalytic domain which can be 
deduced from the high degree of homology between the se­
quence of the catalytically active tryptic fragment (Tk) and 
the catalytic domains of other protein kinases (16).
DISCUSSION
Protein kinases comprise an enzyme family whose members 
although differing widely in size, specificity, and mode of 
regulation, appear to have in common at least one important
structural feature, namely a marked similarity in their cata­
lytic domains. The catalytic moieties of such distinct kinases 
as cAMP- and cGMP-dependent protein kinases, 7 subunit 
of phosphorylase kinase, casein kinase II, epidermal growth 
factor receptor, and pp60"'c in general consist of either a 
~40,000-dalton catalytic subunit or a ~30,000-40,000-dalton 
catalytic domain residing in the carboxyl-terminal region of 
the larger molecule (29-37). All of the protein kinase “cata­
lytic units” reported to date exhibit sequence homology (sum­
marized in Takio et al. (31)). Skeletal muscle myosin light 
chain kinase clearly shares these features. Isolated tryptic and 
chymotryptic fragments of ~30,000-40,000 daltons are enzy­
matically active (Tables I—III, Ref. 10), the catalytic domain 
resides in the carboxyl-terminal half of the molecule, and it 
shows a high degree of homology with the catalytic domains 
of other protein kinases (16).
Mayr and Heilmeyer (10) have proposed a model for myosin 
light chain kinase in which the catalytic unit consists of a 
globular “head” region with a high degree of a-helix, linked 
to a highly asymmetric, enzymatically inactive, “tail” of low 
a-helix content. The resistance of the catalytic domain to 
extensive proteolysis and the rapidity of digestion of the 
remainder of the molecule (Fig. 1) are consistent with this 
model. Under certain conditions we have also observed the 
tail piece and confirm that it is without catalytic activity (data 
not shown). One possible function for the tail unit would be 
in aiding the maintenance of a tertiary structure required for 
optimal enzyme activity. This hypothesis is supported by the 
partial loss of specific activity accompanying generation of 
the active fragment (Figs. 2, 5, and 8). This partial loss could 
not be prevented by the inclusion of MgATP or glycerol in 
the reaction mixture or by doing the proteolysis on ice rather 
than at 22 °C. The inclusion of Ca2+/calmodulin during the 
proteolysis accelerated the loss of activity.2 Mayr and Heil­
meyer (10) report comparable losses in generating their active 
fragment preparations (specific activities: 13-25% that of 
intact enzyme) and in addition report the intriguing finding 
that in at least one case, adding back tail fragment could 
restore much of the activity lost from the isolated head 
fragment.
Although the catalytic domains of protein kinases have 
been studied in detail, there is much less data on the structure 
of the regulatory sites in these enzymes. For polypeptide- 
activated protein kinases such as phosphorylase kinase, 
smooth muscle myosin light chain kinase, epidermal growth 
factor-, or insulin-receptor kinases, relatively large regions 
have been identified as regulator binding, although the spe­
cific residues involved in this interaction have not been iden­
tified (38-42). More is known of the regulatory sites for cyclic 
nucleotides since both cAMP- and cGMP-dependent protein 
kinases are homologous with the Escherichia coli catabolite 
gene activator protein that binds cAMP and for which the 
residues involved in binding have been identified (43, 44). 
Little is known of the sequence determinants involved in 
calmodulin binding to enzymes. We present in Takio et al. 
(16), the amino acid sequence of the carboxyl-terminal half 
of myosin light chain kinase containing both the catalytic and 
calmodulin-binding domains. The evidence that the latter 
occupies the ~30 carboxyl-terminal residues is detailed here 
and in Blumenthal et al. (15). This evidence is as follows: 1) 
the isolated or chemically synthesized carboxyl-terminal, 27- 
residue peptide M13 binds calmodulin with high affinity as 
determined by the ability of the peptide to inhibit (K  s  1 nM) 
myosin light chain kinase activity in an assay in which cal-
J A. M. Edelman, K. Takio, D. K. Blumenthal. R. S. Hansen. K. 


























Ficl. ] ]. S ep ara tio n  of cyanogen brom ide fragm en ts o f in tac t myosin ligh t chain  k inase, T„/Ta, and 
C*3A. CNRr cleavage was performed as described under “Experimental Procedures.” Peptides M l through M13 
in panel n are numbered in order from the  am ino term inus of intact myosin light chain kinase (Ifi). Panels a-c: 
prim ary separation in 6  m  guanidine HC1, 10 n)M phosphate, pH 8. on three TSK  gel filtration columns (one 
G3000SW and two G2000SW, each 7.S X COO mm) connected in series a t a flow rale o f 0.5 m l/m in. Vertical tines 
indicate pooled fractions. Panels d -k: further fractionation of selected pools from T SK  gel filtration o r  a 
SynC'hropak R P-P  (4.1 X 250 mm) column a t a flow rate of 2 m l/m in with gradients formed using solvents A 
(0.1% trifluoroaretic acid in H 20 )  and B (0.08% trifluoroacetic acid in acetonitrile). Panels d - j  fractionation of 
pools containing M5. MS, and M13 or M13" (□) from a-c, respectively. The column was equilihrated at 1(1® B 
and eluted with a linear gradient to 40% R in 40 mm. Panelp, a mixture of pools containing M7 (El) from a and b 
Pane! h; the  corresponding fraction containing M7 and M l 3s (£3) from panel e. For panels g  and h the column was 
equilibrated at 100% A and eluted with a linear gradient to 60?i B in 30 min. a and d, in tact enzyme (0.95 mg): b 
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Fr<; 12. S chem atic  mode) of myosin ligh t chain  k inase show ing am ino- and  carboxy l-term inal 
sequences o f p roduc ts  o f lim ited  try p tic  and  chym otryp tic  cleavage. Bar represent? the entire molecule 
(—(>50 residues). Arrows indicate points of cleavage th a t yield the fragm ent indicated above the arrow. Carboxyl- 
term inal tryptic clcavage for T ./1V  occurs a t either the  solid or the  dashed arrow. T he hatched section indicates 
the  approxim ate location of the  catalytic domain (see “Results”). Mil). M 13\ and M l 3' are the carboxyl-terminal 
cyanogen bromide peptides derived from intact enzyme, T.,/T,,, and CV55, respectively. Sequences are in the one- 
letter code for amino acids.
modulin is siibsa titrating (15). 2) Proteolyzed forms of the 
enzyme (0^37, CfJ36, Ctf35) differing greatly in their abilities 
to be activated by calmodulin (Table II) had identical amino 
termini. 3) The calmodulin-independent form (C^35) was 
found to be missing 19 of its carboxyl-terminal 27 residues 
while in calmodulin-dependent forms (T,,/Tfl) this region was 
largely intact (Figs. 11, 12). 4) CNBr digests of the calmodu­
lin-dependent enzyme forms (native and T„/Trt) inhibited 
calmodulin activation with /C values of 4.5 and 1.3 nM, 
respectively, indicating that peptides M13 and M13' were 
able to bind calmodulin with high affinity in an unfractionated 
digest (15). However, when the calmodulin-independent en­
zyme described here (0^35) was subjected to CNBr cleavage 
and tested, there was little inhibition of calmodulin activation 
(Ki =  170 nM) suggesting that the octapeptide M 13’’ does not 
retain the principal determinants required for calmodulin 
binding. The small degree of inhibition that was observed 
could be accounted for by a slight contamination of Cj35 with 
a calmodulin-dependent form.
To date, there have been two other reports describing 
calmodulin-independent forms of skeletal muscle myosin light 
chain kinase. Tanaka et al. ( i l )  used high concentrations of 
trypsin (trypsin/kinase: > 1,0, w/w) to create a calmodulin- 


















(0.001, Fig. 2; 0.03, Mayr and Heilmeyer <10)) the calmodulin - 
dependent forms T„ and Tjj were observed. It is therefore 
likely that at high trypsin concentrations further degradation 
at multiple sites occurs. At the carboxyl terminus, this cleav­
age might occur at . . ,  KRRWKKN , , .  which would be 
expected to lead to calmodulin-independent activity (Fig. 12). 
We have also observed that digestion at higher trypsin con­
centrations will eventually lead to the development of cal­
modulin-independent activity (data not shown). Srivastava 
and Hartshorne (13) described a 65,000-dalton chymotryptic 
fragment whose activity was not regulated by calmodulin and 
which could be phosphorylated (0.8 mol of 32P/mol of frag­
ment) by cAMP-dependent protein kinase. We have found 
that phosphorylation by cAMP-dependent protein kinase (1.2 
mol of 32P/mo) of myosin light chain kina3e. Ref. 9) quite 
probably occurs between the amino terminus of T„ and that 
of Tj (data not shown). Therefore, the fragment of Srivastava 
and Hartshorne could be similar in structure to T„, but with 
a slightly longer amino terminus and shorter carboxyl termi­
nus. Since their digestion was performed in the presence of 
calmodulin, whereas ours lacked it, different digestion prod­
ucts might be expected. Nevertheless, we have been unable to 
observe this 65,000-dalton chymotryptic fragment even when 
digestion was performed in the presence of Cas+-calmodulin 
(data not shown). Although differences in other reaction 
conditions such as salt concentration, presence of sulfhydryl 
reagents or chelators, and type of buffer employed could 
conceivably account for these differences, this appears not to 
be the case as we have observed no significant differences in 
fragmentation pattern with changes in these variables. We 
therefore, at present, have no explanation for these discrepant 
results.
All calmodulin-requiring enzymes discovered to date have 
been reported to be rendered calmodulin-insensitive by lim­
ited proteolytic digestion (reviewed in Ref. 45). The fact that 
degradation induces an activity seen in the absence of cal­
modulin, implies that a calmodulin-dependent enzyme in its 
resting state is “internally inhibited” and that either prote­
olysis or calmodulin binding can relieve the enzyme of this 
inhibition. Once proteolyzed in this fashion (e.£. Cs35), the 
enzyme would therefore be incapable of any further responses 
to calmodulin, that is, it would be calmodulin-independent. 
The mechanism of activation of the cyclic nucleotide-depend­
ent protein kinases by cAMP or cGMP could be thought of 
in an analogous manner. That is, the binding of the cyclic 
nucleotide either causes the dissociation of the inhibitory (R) 
subunits in the case of cAMP-dependent protein kinase, or in 
the case of cGMP-dependent protein kinase, causes a confor­
mational change in the enzyme relieving it of a resting inhi­
bition.
To explain the different modes of interaction with calmo­
dulin of the chymotryptic fragments (0^37, C^36, C;!35) we 
propose that between the catalytic and calmodulin-binding 
domains there is an “inhibitory” domain. Thus it would 
appear that Ctf36, a form with a poor apparent affinity for, 
but complete dependence on, calmodulin has lost some of its 
calmodulin-binding domain but still retains its inhibitory 
domain. Proteolysis of 0^36 to yield calmodulin-independent 
C#35 may involve either the removal of part of the inhibitory 
domain or a loosening of the tertiary structure thereby re­
moving the inhibitory domain from a proximity to the active 
center. Several aspects of the purification of C^35 are consist­
ent with the latteT possibility. It was observed that during 
purification, the relative proportion of activity found in the 
absence of calmodulin rose (from about 50% to 100%) even 
though proteolysis had been terminated after only 20 min
(Table III, Figs, 8 and 9). This can be explained if following 
proteolysis the enzyme underwent a slow transition (during 
the purification) from a constrained “inhibited" conformation 
to a less constrained “non-inhibited” conformation. Further­
more, if this were the case, then the apparent calmodulin- 
dependent activity would not be recovered in any fractions 
from the affinity column. Fig. 9 shows this to be the case. 
Also a transition to a less constrained form would be expected 
to result in an increased asymmetry to the fragment, an idea 
supported by the observation that the calmodulin-independ­
ent activity eluted from the HPLC gel filtration column 
slightly in advance of the calmodulin-dependent activity. 
Also, only a single peak o M ^  absorbing material eluted from 
the HPLC column and throughout this peak, Cti35 was the 
only protein species apparent by SDS-PAGE (data not 
shown). In a replicate digestion and purification of Crf35, the 
same overall pattern was repeated (data not shown).
The calmodulin-dependent tryptic-fragments Ta or T^/T^ 
showed modest decreases in the ability to be activated by 
calmodulin (Table II) and also were found to be missing the 
carboxyl-terminal 8 or 9 residues (Fig. 12). It is therefore 
conceivable that these residues participate in calmodulin 
binding. Nevertheless, M13 minus these carboxyl-terminal 
residues and M13 in its complete sequence (lacking only 
carboxyl-terminal homoserine) have been chemically synthe­
sized and, if anything, the former shows a slight increase in 
affinity for calmodulin.^ This apparent inconsistency may be 
due to differences in the precise way the peptide and intact 
enzyme interact with calmodulin (suggested also by the stud­
ies of Blumenthal et a l  (15)). Alternatively the tryptic frag­
ments may be slightly defective in the ability to convert 
binding into activation.
Finally, since the calmodulin-dependent tryptic fragments 
have the carboxyl-terminal sequence lAVSAANRFKk 
whereas these residues are missing from the calmodulin- 
independent form (C^35), this sequence would appear to con­
tain critical determinants for calmodulin binding. The possi­
ble importance of these residues for this interaction is cur­
rently under active investigation.
Achnoiuledgments—We are grateful to  Barbara Flug and Floyd 
Kennedy for preparation of myosin light chain kinase and mixed 
myosin light chains, M aria Harrylock for isolation of peptides for 
sequencing, Roger Wade for amino acid analysis, and Evelyn Mercier 
for secretarial assistance.
REFERENCES
1. Adelstein, R. S., and Eisenberg, E. (1980) Annu. Rev. Biochem.
4 9 , 921-956
2. Stull, J . T., Nunnally, M. H., Moore, R. I-., and Blumenthal, D.
K. (1985) Adv. Enzym e Regu! 2 3 , in press
3. Nunnally, M. H., and Stull, J. T. (1984) J. Biol. Chem. 2 5 9 ,
1776-1780
4. Nunnally, M. H .p Rybicki, S. B,, and Stull, J. T. (1985) J . Bio!.
Chem. 2 6 0 , 1020-1026
5. Pires, E. M. V., and Perry, S. V. (1977) Biochem J. 1 6 7 , 137­
146
6. Yazawa, M., and Yagi, K. (1978) J. Biochem. (Tokyo) 8 4 , 1259­
1265
7. B lum enthal, D. K„ and Stull, J .T .  (1980) Biochemistry 19 ,5608­
5614
8. Crouch, T. H„ Hoiroyde, M. J., Collins, J. H , Solaro, R. J ., and
Potter, J, D. (1981) Biochemistry 2 0 , 6318-G325
9. Edelm an, A. M,, and Krebs, E. G. <1982) FEBS Lett. 1 3 8 , 293­
298
10. Mayr, G. W., and Heilmeyer, L. M. G., Jr. (1983) Biuchemintry 
22 ,4316-4326














Domains in Myosin Light Chain Kinase 11285
11. T anaka, T .. Naka, M., and Hidaka, H. (1980) Biochem. Biophys.
Res. Commun. 92 , 313-318
12. W aisman, D. M-, Singh, T. J ., and  Wang, J , H, (1978) J. RioL
Chem. 2 5 3 , 3387-3390
13. Srivastava, S., and H artshorne, D. J. (1983) Biochem. Biophys.
Res. Commun. 1 1 0 ,7 0 1 -7 0 8
14. Olwin, B. B., Edelm an, A, M., Krebs, E, G , and Storm , D, B.
(1984) J . Biol Chem. 2 5 9 , 10949-10955 
1&. B lum enthal, D. K., Takio, K., Edelman, A. M., Charbonneau, H., 
T itan i, K., W alsh, K, A., and Krebs, E. G, (1985) Proc. Natl. 
Acad. Sci. V. S. A. 8 2 ,  3187-3191
16. Takio, K-, B lum enthal, D. K., Edelman, A. M., W alsh, K. A.,
Krebs, E. G., and Titani, K. (1985) Biochemistry, in press
17. Kakiuchi, S., Sobue, K-, Yamazaki, R.f Kambayashi, J., Sakon,
M„ and Kosaki, G. (1981) FEBS Lett. 1 2 6 , 203-207
18. Takio, K., Sraith, S. B., W alsh, K, A., Krebs, E. G., and T itani,
K, (1983) J. B iol Chem. 2 5 8 , 5531-5536
19. Heinrikson, R. L., and M eredith, S. C. (1984) Anal. Biochem.
136, 6o-74
20. Knoop, D. R., Morgan, E. T ., T srr, G. E., and Coon, M, J. (1982)
J. Biol. Chem. 2 5 7 ,  8472-8480
21. Hunkapiller, M. W., Hewiek, R. M., Dreyer, W. J,, and Hood, L.
E. (1983) M ethods E nzym ol 91 ,3 9 9 -4 1 3
22. Hunkapiller, M. W., and Hood, L. E, (1983) Method* Enzymol.
9 1 , 486-493
23. Ericsson, L. H., W ade, R. I)-. Gagnon, J., McDonald, R, M.,
Granberg, R. R„ and W alsh, K. A. (1977) in Solid Phase 
Methods in Protein Sequence Analyst# (Previero, A,, and Col- 
etti-Previero, M. A., eds) pp. 137-142, E lsevier/N orth-H olland, 
Am sterdam
24. Laemmli, U. K- (1970) N ature  2 2 7 , 680-685
25. Bradford. M. M. (1976) Anal. Biochem. 7 2 , 248-254
26. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J.
(1951) J. Biol. Chem. 1 9 3 , 265-275
27. Peterson, G. L. (1977) Anal. Biochem. 8 3 ,  346-356
28. Klee, C. B, (1977) Biochemistry 1 6 , 1017-1024
29. Shoji, S., Ericsson, L. H., W alsh, K. A., Fischer, E. H .,and  T itani.
K. (1983) Biochemistry 2 2 , 3702-3709
30. Inoue, M., Kishimoto, A., Takai, Y., and Nishizuka, Y. (1976) J.
Biol. Ckem. 2 5 1 , 4476-4478
31. Takio, K„ Wade, R. D„ Sm ith, S. B., Krebs, E. G„ W alsh, K. A.,
and Titani, K. (1984) Biochemistry 2 3 , 4207-4218
32. Reimann, E. M., T itani, K., Ericsson, L. H., Wade, R. D,, Fischer,
E. H., and W alsh, K. A. (1984) Biochemistry 2 3 , 4185-4192
33. Meggio, F., and P inna, L. A- (1984) Eur. J. Biochem- 1 4 5 , 593­
599
34. Basu, M., Biswas, R-, and Das, M. (1984) Nature 3 1 1 , 477-480
35. Chinkers, M., and Brugge, J. S. (1984) J. Biol. Chem. 259 ,1 1 5 3 4 -
U 642
36. Brugge, J. S., and Darrow, D. (1984) J. Biol. Chem. 2 5 9 , 4550­
4557
37. Levinson, A. D., Courtneidge, S. A., and Bishop, J, M. (1931)
Proc. Natl. Acad. Sci. U. S. A. 78, 1624-1628
38. Picton, C,, Klee, C. B., and Cohen, P, (1980) Eur. J. Biochem.
111,553-561
39. Foyt, H. L., Guerriero, V., Jr., and  Means, A, R. (1985) J. Biol.
Chem. 2 6 0 , 7765-7774
40. Linsley, P . S., and Fox, C. F, (1980) J. Supram ol Struct. 14 ,
461-471
41. Ullrich, A., Coussens, L., Hayflick, J. S., Dull, T. J., Gray, A.,
Tam , A. W., Lee, J., Yarden, Y., Libermann, T. A., Schlessin- 
ger, J ., Downward, J., Mayes, E. L. V., W hittle, N., Waterfield, 
M. D., and Seeburg, P. H. (1984) N ature  3 0 9 , 418-425.
42. Yip, C. C„ Yeung, C. W. T., and Moule, M. L. (1978) J. Biol.
Chem. 2 5 3 , 1743-1745
43. Weber, I. T., Takio, K., T itani, K., and Steitz, T. A. (1982) /V:-<
N atl Acad. Sci. U. S. A. 7 9 , 7679-7683
44. McKay, D., and Steitz, T, A. (1981) Nature  2 9  0, 744-749
45. Krinks, M. H„ Haiech, J., Rhoads, A„ and Klee, C. B, (1984)
Adv. Cyclic Nucleotide Res. 1 6 , 31-47
1
I
D
ow
nloaded 
from 
w
ww
.jbc.org 
at UNIV 
OF 
UTAH 
on 
Septem
ber 15, 2006
